Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Sep 7;13:964540. doi: 10.3389/fphar.2022.964540

Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer

Xing Feng 1,2, Xiaoling Xiong 3, Shenglin Ma 4,*
PMCID: PMC9490400  PMID: 36160393

In the published article, there was an error in the author list. Author Xing Feng was erroneously listed as corresponding author. The corrected author list appears below:

“Xing Feng1,2, Xiaoling Xiong3 and Shenglin Ma4*

*Correspondence: Shenglin Ma, mashenglin0607@163.com”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES